Extracorporeal Shockwave Therapy (ESWT) has shifted from a niche, high-tech gadget to a standard-of-care intervention for chronic tendinopathies (plantar fasciitis, tennis elbow, patellar tendinopathy), calcific tendinitis, and delayed bone healing. In Australia, where sports injuries and an aging active population drive demand, a properly qualified shockwave clinician can see significant clinical outcomes—and a strong return on investment.

| | Clinical Relevance | |------------|------------------------| | Physics: Focused vs. Radial | Focused (depth >3cm) for bone/non-union; Radial (3–5cm spread) for soft tissue. | | Energy Flux Density (EFD) | How to dose (low, mid, high) – most Aussie courses teach in mJ/mm² or bar/pressure. | | Patient selection & red flags | Tumour, pregnancy over spine, coagulopathy, nerve root vs. peripheral entrapment. | | Ultrasound integration | Real-time guided shockwave (e.g., targeting calcific deposit in supraspinatus). | | Treatment protocols | Frequency (weekly x 3–4), number of pulses (2,000–3,000 per site), anaesthesia (topical/local – rarely needed). | | Adverse events | Petechiae, mild swelling, transient pain increase – vs. serious (tendon rupture if too high energy on degenerate tissue). | 4. Cost-Benefit for Australian Practices Training investment: $800–$2,200 (one-off) Device cost (new): $8,000–$25,000 AUD for radial; $35k–$70k for focused + radial combo. Typical patient fee (private): $60–$120 per shockwave session (often 3–6 sessions).

With 4–6 patients/week at $80/session, training pays for itself in ~4 weeks. Device payback 3–9 months.

By [Author/Practice Name] | Updated for 2025